Study to Evaluate the Efficacy and Safety of a Rilpivarine-based Antiretroviral Tratment Regimen in HIV- Infected Patients With Liver Metabolic Disease Who Maintain Udetectable HIV Viral Load
Clinical trial NCT05898841 · COMPLETED
Trial details
- NCT number
- NCT05898841
- Sponsor
- Fundacion SEIMC-GESIDA
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2023-05-26
- Primary completion
- 2025-07-07
- Enrollment
- 63
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.